Literature DB >> 2703547

New enzyme immunoassay for detecting total, type I, and type II intrinsic factor antibodies.

H M Waters1, C Smith, J E Howarth, D W Dawson, I W Delamore.   

Abstract

A method for the detection of total, type I, and type II intrinsic factor antibodies was devised. The technique comprises a two-site solid phase enzyme linked immunosorbent assay (ELISA), with human intrinsic factor conjugated with horseradish peroxidase as label and attached to polystyrene tubes as solid phase. One conjugation provides sufficient material to assay more than 10,000 patient samples. The label proved stable during the course of this evaluation and was still in use more than 12 months after preparation. When applied to 45 serum samples from cases of pernicious anaemia, intrinsic factor antibodies were shown in 30 (67%). Simplicity, high capacity, low cost and label stability, combined with relatively high clinical sensitivity make the method suitable for cost effective screening of large numbers of samples. Simple modifications to the basic assay reagents permitted type I and type II intrinsic factor antibodies to be differentiated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703547      PMCID: PMC1141874          DOI: 10.1136/jcp.42.3.307

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Intrinsic-factor-inhibiting substance in serum of orally treated patients with pernicious anaemia.

Authors:  M SCHWARTZ
Journal:  Lancet       Date:  1958-07-12       Impact factor: 79.321

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Detection of type I and type II antibodies to intrinsic factor.

Authors:  D A Conn
Journal:  Med Lab Sci       Date:  1986-04

4.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Results with radioisotopic assay of serum B12 using serum binding agent.

Authors:  D M Matthews; R Gunasegaram; J C Linnell
Journal:  J Clin Pathol       Date:  1967-09       Impact factor: 3.411

6.  Status of laboratory testing in the diagnosis of megaloblastic anemia.

Authors:  J Lindenbaum
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

7.  Effect of serum vitamin B 12 binding on intrinsic factor antibody detection in pernicious anaemia.

Authors:  H A Ghazi
Journal:  Acta Haematol       Date:  1972       Impact factor: 2.195

8.  Increased sensitivity of detection of the blocking (type I) anti-intrinsic factor antibody.

Authors:  R E Nimo; R Carmel
Journal:  Am J Clin Pathol       Date:  1987-12       Impact factor: 2.493

9.  Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women.

Authors:  R Carmel; C S Johnson
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

10.  RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITY.

Authors:  K S GOTTLIEBLAU; L R WASSERMAN; V HERBERT
Journal:  Blood       Date:  1965-06       Impact factor: 22.113

View more
  2 in total

1.  Do intrinsic factor antibodies assays provide univocal answers in Biermer's disease?

Authors:  Jean-Benoît Corcuff; Stéphanie Morel; Agnès Georges; Karine de Bosredon; Laurence Bordenave
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  High incidence of type II autoantibodies in pernicious anaemia.

Authors:  H M Waters; D W Dawson; J E Howarth; C G Geary
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.